;PMID: 10206488
;source_file_753.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..30] = [t:0..30]
;1)section:[e:35..80] = [t:35..80]
;2)sentence:[e:84..206] = [t:84..206]
;3)section:[e:210..278] = [t:210..278]
;4)section:[e:282..374] = [t:282..374]
;5)sentence:[e:378..600] = [t:378..600]
;6)sentence:[e:601..799] = [t:601..799]
;7)sentence:[e:800..960] = [t:800..960]
;8)sentence:[e:961..1118] = [t:961..1118]
;9)sentence:[e:1119..1257] = [t:1119..1257]
;10)sentence:[e:1258..1423] = [t:1258..1423]
;11)sentence:[e:1424..1490] = [t:1424..1490]
;12)sentence:[e:1491..1726] = [t:1491..1726]
;13)section:[e:1730..1775] = [t:1730..1775]

;section 0 Span:0..30
;Pancreas  1999 Apr;18(3):294-9
(SEC
  (FRAG (RB:[0..8] Pancreas) (CD:[10..14] 1999) (CC:[15..22] Apr;18-LRB-)
        (CD:[22..23] 3) (-RRB-:[23..24] -RRB-) (CD:[24..28] :294) (::[28..29] -)
        (CD:[29..30] 9)))

;section 1 Span:35..80
;Comment in:   Pancreas. 2001 Jan;22(1):108-9.
(SEC
  (FRAG (NNP:[35..42] Comment) (VBZ:[43..45] in) (DT:[45..46] :)
        (NNP:[49..57] Pancreas) (.:[57..58] .) (CD:[59..63] 2001)
        (CC:[64..71] Jan;22-LRB-) (CD:[71..72] 1) (-RRB-:[72..73] -RRB-)
        (CD:[73..77] :108) (::[77..78] -) (CD:[78..80] 9.)))

;sentence 2 Span:84..206
;Detection of K-ras and p53 gene mutations in pancreatic juice for the
;diagnosis  of intraductal papillary mucinous tumors.
;[97..102]:gene-rna:"K-ras"
;[107..110]:gene-rna:"p53"
;[168..205]:malignancy:"intraductal papillary mucinous tumors"
(SENT
  (NP-HLN
    (NP (NN:[84..93] Detection))
    (PP (IN:[94..96] of)
      (NP
        (NP (NN:[97..102] K-ras)
          (NML-1 (-NONE-:[102..102] *P*)))
        (CC:[103..106] and)
        (NP (NN:[107..110] p53)
          (NML-1 (NN:[111..115] gene) (NNS:[116..125] mutations)))))
    (PP-LOC (IN:[126..128] in)
      (NP (JJ:[129..139] pancreatic) (NN:[140..145] juice)))
    (PP (IN:[146..149] for)
      (NP
        (NP (DT:[150..153] the) (NN:[154..163] diagnosis))
        (PP (IN:[165..167] of)
          (NP (JJ:[168..179] intraductal) (JJ:[180..189] papillary)
              (JJ:[190..198] mucinous) (NNS:[199..205] tumors)))))
    (.:[205..206] .)))

;section 3 Span:210..278
;Kaino M, Kondoh S, Okita S, Hatano S, Shiraishi K, Kaino S, Okita K.
(SEC
  (FRAG (NNP:[210..215] Kaino) (NNP:[216..218] M,) (NNP:[219..225] Kondoh)
        (NNP:[226..228] S,) (NNP:[229..234] Okita) (NNP:[235..237] S,)
        (NNP:[238..244] Hatano) (NNP:[245..247] S,) (NNP:[248..257] Shiraishi)
        (NNP:[258..259] K) (,:[259..260] ,) (NNP:[261..266] Kaino)
        (NNP:[267..269] S,) (NNP:[270..275] Okita) (NNP:[276..278] K.)))

;section 4 Span:282..374
;First Department of Internal Medicine, Yamaguchi University School of
;Medicine,  Ube, Japan.
(SEC
  (FRAG (NNP:[282..287] First) (NNP:[288..298] Department) (IN:[299..301] of)
        (NNP:[302..310] Internal) (NNP:[311..319] Medicine) (,:[319..320] ,)
        (NNP:[321..330] Yamaguchi) (NNP:[331..341] University)
        (NNP:[342..348] School) (IN:[349..351] of) (NNP:[352..360] Medicine)
        (,:[360..361] ,) (NNP:[363..366] Ube) (,:[366..367] ,)
        (NNP:[368..373] Japan) (.:[373..374] .)))

;sentence 5 Span:378..600
;The aim of this study was to investigate mutations of the K-ras oncogene and
;the  p53 tumor suppressor gene in pancreatic juice and to evaluate our method
;for the  diagnosis of intraductal papillary mucinous tumors (IPMT).
;[436..441]:gene-rna:"K-ras"
;[460..463]:gene-rna:"p53"
;[555..592]:malignancy:"intraductal papillary mucinous tumors"
;[594..598]:malignancy:"IPMT"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[378..381] The) (NN:[382..385] aim))
      (PP (IN:[386..388] of)
        (NP (DT:[389..393] this) (NN:[394..399] study))))
    (VP (VBD:[400..403] was)
      (S-PRP-PRD
        (NP-SBJ (-NONE-:[403..403] *))
        (VP
          (VP (TO:[404..406] to)
            (VP (VB:[407..418] investigate)
              (NP
                (NP (NNS:[419..428] mutations))
                (PP (IN:[429..431] of)
                  (NP
                    (NP (DT:[432..435] the) (NN:[436..441] K-ras)
                        (NN:[442..450] oncogene))
                    (CC:[451..454] and)
                    (NP (DT:[455..458] the) (NN:[460..463] p53)
                      (NML (NN:[464..469] tumor) (NN:[470..480] suppressor))
                      (NN:[481..485] gene)))))
              (PP-LOC (IN:[486..488] in)
                (NP (JJ:[489..499] pancreatic) (NN:[500..505] juice)))))
          (CC:[506..509] and)
          (VP (TO:[510..512] to)
            (VP (VB:[513..521] evaluate)
              (NP
                (NP (PRP$:[522..525] our) (NN:[526..532] method))
                (PP (IN:[533..536] for)
                  (NP
                    (NP (DT:[537..540] the) (NN:[542..551] diagnosis))
                    (PP (IN:[552..554] of)
                      (NP
                        (NP (JJ:[555..566] intraductal)
                            (JJ:[567..576] papillary) (JJ:[577..585] mucinous)
                            (NNS:[586..592] tumors))
                        (NP (-LRB-:[593..594] -LRB-) (NN:[594..598] IPMT)
                            (-RRB-:[598..599] -RRB-))))))))))))
    (.:[599..600] .)))

;sentence 6 Span:601..799
;Pancreatic juice was  collected endoscopically from 12 patients with IPMT who
;underwent surgical  resection (eight carcinomas and four adenomas) and eight
;cases without evident  pancreatic diseases.
;[670..674]:malignancy:"IPMT"
;[716..726]:malignancy:"carcinomas"
;[736..744]:malignancy:"adenomas"
(SENT
  (S
    (NP-SBJ-2 (JJ:[601..611] Pancreatic) (NN:[612..617] juice))
    (VP (VBD:[618..621] was)
      (VP (VBN:[623..632] collected)
        (NP-2 (-NONE-:[632..632] *))
        (ADVP-MNR (RB:[633..647] endoscopically))
        (PP (IN:[648..652] from)
          (NP
            (NP
              (NP
                (NP (CD:[653..655] 12) (NNS:[656..664] patients))
                (PP (IN:[665..669] with)
                  (NP (NN:[670..674] IPMT))))
              (SBAR
                (WHNP-1 (WP:[675..678] who))
                (S
                  (NP-SBJ-1 (-NONE-:[678..678] *T*))
                  (VP (VBD:[679..688] underwent)
                    (NP (JJ:[689..697] surgical) (NN:[699..708] resection)
                      (PRN (-LRB-:[709..710] -LRB-)
                        (NP
                          (NP (CD:[710..715] eight) (NNS:[716..726] carcinomas))
                          (CC:[727..730] and)
                          (NP (CD:[731..735] four) (NNS:[736..744] adenomas)))
                        (-RRB-:[744..745] -RRB-)))))))
            (CC:[746..749] and)
            (NP
              (NP (CD:[750..755] eight) (NNS:[756..761] cases))
              (PP (IN:[762..769] without)
                (NP (JJ:[770..777] evident) (JJ:[779..789] pancreatic)
                    (NNS:[790..798] diseases))))))))
    (.:[798..799] .)))

;sentence 7 Span:800..960
;DNA was extracted and both genes were examined by  polymerase chain reaction
;single-strand conformation polymorphism (PCR-SSCP)  analysis and direct
;sequencing.
;[822..832]:gene-rna:"both genes"
;[851..861]:gene-protein:"polymerase"
(SENT
  (S
    (S
      (NP-SBJ-2 (NN:[800..803] DNA))
      (VP (VBD:[804..807] was)
        (VP (VBN:[808..817] extracted)
          (NP-2 (-NONE-:[817..817] *)))))
    (CC:[818..821] and)
    (S
      (NP-SBJ-1 (DT:[822..826] both) (NNS:[827..832] genes))
      (VP (VBD:[833..837] were)
        (VP (VBN:[838..846] examined)
          (NP-1 (-NONE-:[846..846] *))
          (PP-MNR (IN:[847..849] by)
            (NP
              (NP
                (NML
                  (NML (NN:[851..861] polymerase) (NN:[862..867] chain)
                       (NN:[868..876] reaction))
                  (NML
                    (NML (JJ:[877..883] single) (HYPH:[883..884] -)
                         (NN:[884..890] strand))
                    (NN:[891..903] conformation) (NN:[904..916] polymorphism)))
                (NML (-LRB-:[917..918] -LRB-) (NN:[918..921] PCR)
                     (HYPH:[921..922] -) (NN:[922..926] SSCP)
                     (-RRB-:[926..927] -RRB-))
                (NN:[929..937] analysis))
              (CC:[938..941] and)
              (NP (JJ:[942..948] direct) (NN:[949..959] sequencing)))))))
    (.:[959..960] .)))

;sentence 8 Span:961..1118
;In addition, surgically resected specimens were  analyzed for both genes by
;the same methods, and p53 overexpression was  investigated
;immunohistochemically.
;[1023..1033]:gene-rna:"both genes"
;[1059..1062]:gene-generic:"p53"
(SENT
  (S
    (S
      (PP (IN:[961..963] In)
        (NP (NN:[964..972] addition)))
      (,:[972..973] ,)
      (NP-SBJ-2
        (ADJP (RB:[974..984] surgically) (JJ:[985..993] resected))
        (NNS:[994..1003] specimens))
      (VP (VBD:[1004..1008] were)
        (VP (VBN:[1010..1018] analyzed)
          (NP-2 (-NONE-:[1018..1018] *))
          (PP (IN:[1019..1022] for)
            (NP (DT:[1023..1027] both) (NNS:[1028..1033] genes)))
          (PP-MNR (IN:[1034..1036] by)
            (NP (DT:[1037..1040] the) (JJ:[1041..1045] same)
                (NNS:[1046..1053] methods))))))
    (,:[1053..1054] ,) (CC:[1055..1058] and)
    (S
      (NP-SBJ-1 (NN:[1059..1062] p53) (NN:[1063..1077] overexpression))
      (VP (VBD:[1078..1081] was)
        (VP (VBN:[1083..1095] investigated)
          (NP-1 (-NONE-:[1095..1095] *))
          (ADVP-MNR (RB:[1096..1117] immunohistochemically)))))
    (.:[1117..1118] .)))

;sentence 9 Span:1119..1257
;K-ras point mutations were detected in  pancreatic juice from all 12 patients
;(100%) and p53 mutations were detected in  five of 12 (42%).
;[1119..1124]:gene-rna:"K-ras"
;[1125..1140]:variation-type:"point mutations"
;[1208..1211]:gene-rna:"p53"
(SENT
  (S
    (S
      (NP-SBJ-2 (NN:[1119..1124] K-ras)
         (NN:[1125..1130] point) (NNS:[1131..1140] mutations))
      (VP (VBD:[1141..1145] were)
        (VP (VBN:[1146..1154] detected)
          (NP-2 (-NONE-:[1154..1154] *))
          (PP-LOC (IN:[1155..1157] in)
            (NP
              (NP (JJ:[1159..1169] pancreatic) (NN:[1170..1175] juice))
              (PP (IN:[1176..1180] from)
                (NP (DT:[1181..1184] all) (CD:[1185..1187] 12)
                    (NNS:[1188..1196] patients)
                  (PRN (-LRB-:[1197..1198] -LRB-)
                    (NP (CD:[1198..1201] 100) (NN:[1201..1202] %))
                    (-RRB-:[1202..1203] -RRB-)))))))))
    (CC:[1204..1207] and)
    (S
      (NP-SBJ-1 (NN:[1208..1211] p53) (NNS:[1212..1221] mutations))
      (VP (VBD:[1222..1226] were)
        (VP (VBN:[1227..1235] detected)
          (NP-1 (-NONE-:[1235..1235] *))
          (PP-LOC (IN:[1236..1238] in)
            (NP
              (NP (CD:[1240..1244] five))
              (PP (IN:[1245..1247] of)
                (NP (CD:[1248..1250] 12)
                  (PRN (-LRB-:[1251..1252] -LRB-)
                    (NP (CD:[1252..1254] 42) (NN:[1254..1255] %))
                    (-RRB-:[1255..1256] -RRB-)))))))))
    (.:[1256..1257] .)))

;sentence 10 Span:1258..1423
;They were detected not only in carcinoma but also in adenoma  and there was
;no difference between the mutations detected in pancreatic juice  and
;surgical specimens.
;[1289..1298]:malignancy:"carcinoma"
;[1311..1318]:malignancy:"adenoma"
;[1356..1369]:variation-event:"the mutations"
(SENT
  (S
    (S
      (NP-SBJ-1 (PRP:[1258..1262] They))
      (VP (VBD:[1263..1267] were)
        (VP (VBN:[1268..1276] detected)
          (NP-1 (-NONE-:[1276..1276] *))
          (PP-LOC
            (CONJP (RB:[1277..1280] not) (RB:[1281..1285] only))
            (PP (IN:[1286..1288] in)
              (NP (NN:[1289..1298] carcinoma)))
            (CONJP (CC:[1299..1302] but) (RB:[1303..1307] also))
            (PP (IN:[1308..1310] in)
              (NP (NN:[1311..1318] adenoma)))))))
    (CC:[1320..1323] and)
    (S
      (NP-SBJ (EX:[1324..1329] there))
      (VP (VBD:[1330..1333] was)
        (NP-PRD
          (NP (DT:[1334..1336] no) (NN:[1337..1347] difference))
          (PP (IN:[1348..1355] between)
            (NP
              (NP (DT:[1356..1359] the) (NNS:[1360..1369] mutations))
              (VP (VBN:[1370..1378] detected)
                (NP (-NONE-:[1378..1378] *))
                (PP-LOC (IN:[1379..1381] in)
                  (NP
                    (NP (JJ:[1382..1392] pancreatic) (NN:[1393..1398] juice))
                    (CC:[1400..1403] and)
                    (NP (JJ:[1404..1412] surgical) (NNS:[1413..1422] specimens))))))))))
    (.:[1422..1423] .)))

;sentence 11 Span:1424..1490
;No mutations were found in any cases without pancreatic  diseases.
(SENT
  (S
    (NP-SBJ-1 (DT:[1424..1426] No) (NNS:[1427..1436] mutations))
    (VP (VBD:[1437..1441] were)
      (VP (VBN:[1442..1447] found)
        (NP-1 (-NONE-:[1447..1447] *))
        (PP (IN:[1448..1450] in)
          (NP
            (NP (DT:[1451..1454] any) (NNS:[1455..1460] cases))
            (PP (IN:[1461..1468] without)
              (NP (JJ:[1469..1479] pancreatic) (NNS:[1481..1489] diseases)))))))
    (.:[1489..1490] .)))

;sentence 12 Span:1491..1726
;These findings suggest that alterations of K-ras and p53 gene are  common
;events in the development of IPMT and that genetic analysis of them in 
;pancreatic juice can be a useful tool for the clinical diagnosis of IPMT
;before  surgery.
;[1534..1539]:gene-rna:"K-ras"
;[1544..1547]:gene-rna:"p53"
;[1594..1598]:malignancy:"IPMT"
;[1705..1709]:malignancy:"IPMT"
(SENT
  (S
    (NP-SBJ (DT:[1491..1496] These) (NNS:[1497..1505] findings))
    (VP (VBP:[1506..1513] suggest)
      (SBAR
        (SBAR (IN:[1514..1518] that)
          (S
            (NP-SBJ
              (NP (NNS:[1519..1530] alterations))
              (PP (IN:[1531..1533] of)
                (NP
                  (NP (NN:[1534..1539] K-ras)
                    (NML-1 (-NONE-:[1539..1539] *P*)))
                  (CC:[1540..1543] and)
                  (NP (NN:[1544..1547] p53)
                    (NML-1 (NN:[1548..1552] gene))))))
            (VP (VBP:[1553..1556] are)
              (NP-PRD
                (NP (JJ:[1558..1564] common) (NNS:[1565..1571] events))
                (PP (IN:[1572..1574] in)
                  (NP
                    (NP (DT:[1575..1578] the) (NN:[1579..1590] development))
                    (PP (IN:[1591..1593] of)
                      (NP (NN:[1594..1598] IPMT)))))))))
        (CC:[1599..1602] and)
        (SBAR (IN:[1603..1607] that)
          (S
            (NP-SBJ
              (NP (JJ:[1608..1615] genetic) (NN:[1616..1624] analysis))
              (PP (IN:[1625..1627] of)
                (NP (PRP:[1628..1632] them)))
              (PP-LOC (IN:[1633..1635] in)
                (NP (JJ:[1637..1647] pancreatic) (NN:[1648..1653] juice))))
            (VP (MD:[1654..1657] can)
              (VP (VB:[1658..1660] be)
                (NP-PRD
                  (NP (DT:[1661..1662] a) (JJ:[1663..1669] useful)
                      (NN:[1670..1674] tool))
                  (PP (IN:[1675..1678] for)
                    (NP
                      (NP (DT:[1679..1682] the) (JJ:[1683..1691] clinical)
                          (NN:[1692..1701] diagnosis))
                      (PP (IN:[1702..1704] of)
                        (NP (NN:[1705..1709] IPMT)))
                      (PP (IN:[1710..1716] before)
                        (NP (NN:[1718..1725] surgery))))))))))))
    (.:[1725..1726] .)))

;section 13 Span:1730..1775
;PMID: 10206488 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1730..1734] PMID) (::[1734..1735] :) (CD:[1736..1744] 10206488)
        (NN:[1745..1746] -LSB-) (NNP:[1746..1752] PubMed) (::[1753..1754] -)
        (NN:[1755..1762] indexed) (IN:[1763..1766] for)
        (NNP:[1767..1775] MEDLINE-RSB-)))
